News

Frontiers4d
Harnessing delta-like ligand 3: bridging biomarker discovery to next-generation immunotherapies in refractory small cell lung cancer
Small cell lung cancer (SCLC), accounting for 10–20% of lung cancers ... highlighting the critical need for reliable biomarkers and innovative therapies. Delta-like ligand 3 (DLL3), a Notch signaling ...
BMJ5d
Assessment of the impact of multi-cancer early detection test screening intervals on late-stage cancer at diagnosis and mortality using a state-transition model
Patient advocacy partners at the American Cancer Society and Friends of Cancer Research will be invited to advise on the best messaging and format that will be of greatest use to communicate this ...